Biologic therapies targeting type 2 inflammation in NSAID−exacerbated respiratory disease
Nonsteroidal anti−inflammatory drug-exacerbated respiratory disease (N−ERD) is an inflammatory airway disease characterized by adult−onset asthma, chronic rhinosinusitis with nasal polyps and hypersensitivity reactions to cyclooxygenase−1 (COX−1) inhibitors. The disease is driven by dysregulated eic...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2026-07-01
|
| Edice: | Frontiers in Immunology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1890964/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|